Genprex Shares Gain as Positive Preclinical Lung Cancer Data to Be Presented at Global Oncology Conference
REQORSA® gene therapy shows promise against hard-to-treat ALK-positive non-small cell lung cancer Clinical-stage gene therapy developer Genprex (GNPX) announced that ...